Use of recombinant congenic strains in mapping disease-modifying genes

News in Physiological Sciences

Volumn 19, Issue 3, 2004, Pages 105-109

  Müllerová, Jana ^a,b   Hozák, Pavel ^a,b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CANCER GENETICS; CANCER SUSCEPTIBILITY; CANCER SUSCEPTIBILITY GENE; CONGENIC ANIMAL; DISEASE MODIFYING GENE; DNA DAMAGE; DNA REPAIR; GENE; GENE IDENTIFICATION; GENE MAPPING; GENETIC ANALYSIS; NONHUMAN; RECOMBINANT CONGENIC STRAIN; REVIEW; TUMOR MODIFYING GENE; ANIMAL; CHROMOSOME MAP; CONGENIC STRAIN; GENETICS; HUMAN; METHODOLOGY; MOUSE; NEOPLASM; TRANSGENIC MOUSE;

ANIMALS; CHROMOSOME MAPPING; HUMANS; MICE; MICE, CONGENIC; MICE, TRANSGENIC; NEOPLASMS;

EID: 3042765588     PISSN: 08861714     EISSN: None     Source Type: Journal    
DOI: 10.1152/nips.01512.2003     Document Type: Review

References (25)

1. Balmain A, Gray J, and Ponder B. The genetics and genomics of cancer. Nat Genet 33, Suppl: 238-244, 2003.
2. Balmain A and Nagase H. Cancer resistance genes in mice: models for the study of tumor modifiers. Trends Genet 14: 139-144, 1998.
3. Bodnar JS, Chatterjee A, Castellani LW, Ross DA, Ohmen J, Cavalcoli J, Wu C, Dains KM, Catanese J, Chu M, Sheth SS, Charugundla K, Demant P, West DB, de Jong P, and Lusis AJ. Positional cloning of the combined hyperlipidemia gene Hyplip1. Nat Genet 30: 110-116, 2002.
4. Brockmann GA and Bevova MR. Using mouse models to dissect the genetics of obesity. Trends Genet 7: 367-376, 2002.
5. Min mutation in intestine and mammary gland. Cancer Res 63: 4533-4537, 2003.
6. Demant P. Genetic resolution of susceptibility to cancer-new perspectives. Semin Cancer Biol 3: 159-166, 1992.
7. Demant P. Cancer susceptibility in the mouse: genetics, biology and implications for human cancer. Nat Rev Genet 4: 721-734, 2003.
8. Demant P and Hart AA. Recombinant congenic strains - a new tool for analyzing genetic traits determined by more than one gene. Immunogenetics 24: 416-422, 1986.
9. Fijneman RJ, van der Valk MA, and Demant P. Genetics of quantitative and qualitative aspects of lung tumorigenesis in the mouse: multiple interacting susceptibility to lung cancer (Sluc) genes with large effects. Exp Lung Res 24: 419-436, 1998.
10. Fortin A, Cardon LR, Tam M, Skamene E, Stevenson MM, and Gros P. Identification of a new malaria susceptibility locus (Char4) in recombinant congenic strains of mice. Proc Natl Acad Sci USA 98: 10793-10798, 2001.
11. Fortin A, Diez E, Rochefort D, Laroche L, Malo D, Rouleau GA, Gros P, and Skamene E. Recombinant congenic strains derived from A/J and C57BL/6J: a tool for genetic dissection of complex traits. Genomics 74: 21-35, 2001.
12. Hamet P. Genes and hypertension: where we are and where we should go. Clin Exp Hypertens 21: 947-960, 1999.
13. Hanahan D and Weinberg RA. The hallmarks of cancer. Cell 100: 57-70, 2000.
14. Mori N, van Wezel T, van der Valk M, Yamate J, Sakuma S, Okumoto M, and Demant P. Genetics of susceptibility to radiation-induced apoptosis in colon: two loci on chromosomes 9 and 16. Mamm Genome 9: 377-380.
15. Reifsnyder PC and Leiter EH. Deconstructing and reconstructing obesity-induced diabetes (diabesity) in mice. Diabetes 51: 825-832, 2002.
16. Ruivenkamp CA, van Wezel T, Zanon C, Stassen AP, Vlcek C, Csikos T, Klous AM, Tripodis N, Perrakis A, Boerrigter L, Groot PC, Lindeman J, Mooi WJ, Meijjer GA, Scholten G, Dauwerse H, Paces V, van Zandwijk N, van Ommen GJ, and Demant P. Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers. Nat Genet 31: 295-300, 2002.
17. Serreze DV, Bridgett M, Chapman HD, Chen E, Richard SD, and Leiter EH. Subcongenic analysis of the Idd13 locus in NOD/Lt mice: evidence for several susceptibility genes including a possible diabetogenic role for beta 2-microglobulin. J Immunol 160: 1472-1478, 1998.
18. Serreze DV, Prochazka M, Reifsnyder PC, Bridgett MM, and Leiter EH. Use of recombinant congenic and congenic strains of NOD mice to identify a new insulin-dependent diabetes resistance gene. J Exp Med 180: 1553-1558, 1994.
19. Stassen AP, Groot PC, Eppig JT, and Demant P. Genetic composition of the recombinant congenic strains. Mamm Genome 7: 55-58, 1996.
20. Szymanska H, Sitarz M, Krysiak E, Piskorowska J, Czarnomska A, Skurzak H, Hart AA, de Jong D, and Demant P. Genetics of susceptibility to radiation-induced lymphomas, leukemias and lung tumors studied in recombinant congenic strains. Int J Cancer 83: 674-678, 1999.
21. Tripodis N and Demant P. Genetic linkage of nuclear morphology of mouse lung tumors to the Kras-2 locus. Exp Lung Res 27: 185-196, 2001.
22. Tripodis N and Demant P. Genetic analysis of three-dimensional shape of mouse lung tumors reveals eight lung tumor shape-determining (Ltsd) loci that are associated with tumor heterogeneity and symmetry. Cancer Res 63: 125-131, 2003.
23. Tripodis N, Hart AA, Fijneman RJ, and Demant P. Complexity of lung cancer modifiers: mapping of thirty genes and twenty-five interactions in half of the mouse genome. J Natl Cancer Inst 93: 1484-1491, 2001.
24. Van Wezel T, Lipoldova M, and Demant P. Identification of disease susceptibility genes (modifiers) in mouse models: cancer and infectious diseases. In: Genotype to Phenotype (2nd ed.). Oxford, UK: BIOS Scientific, 2001, p. 107-129.
25. Vladimirov V, Badalova J, Svobodova M, Havelkova H, Hart AA, Blazkova H, Demant P, and Lipoldova M. Different genetic control of cutaneous and visceral disease after Leishmania major infection in mice. Infect Immun 71: 2041-2046, 2003.